| 000 | 01330 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250517082238.0 | ||
| 264 | 0 | _c20171204 | |
| 008 | 201712s 0 0 eng d | ||
| 022 | _a1949-2553 | ||
| 024 | 7 |
_a10.18632/oncotarget.7491 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aUbezio, Paolo | |
| 245 | 0 | 0 |
_aIntegrated experimental and simulation study of the response to sequential treatment with erlotinib and gemcitabine in pancreatic cancer. _h[electronic resource] |
| 260 |
_bOncotarget _cMar 2016 |
||
| 300 |
_a15492-506 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 |
_aCell Cycle Checkpoints _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aDeoxycytidine _xadministration & dosage |
| 650 | 0 | 4 |
_aErlotinib Hydrochloride _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aModels, Theoretical |
| 650 | 0 | 4 |
_aPancreatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aGemcitabine |
| 700 | 1 | _aFalcetta, Francesca | |
| 700 | 1 | _aCarrassa, Laura | |
| 700 | 1 | _aLupi, Monica | |
| 773 | 0 |
_tOncotarget _gvol. 7 _gno. 13 _gp. 15492-506 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.18632/oncotarget.7491 _zAvailable from publisher's website |
| 999 |
_c25764747 _d25764747 |
||